We found that BRG1 was expressed at significantly higher levels in GBM tumour tissue as compared to non‐tumour brain tissue, while BRM was expressed at lower levels in tumor tissue (Figure 1B). The gene discussed is SMARCA2; the disease is glioblastoma.